Aptamer Group Launces Novel Biomarker Discovery Service
Aptamer Group, a UK-based developer of next-generation synthetic binders, has launched a new biomarker discovery service, providing researchers in pharmaceuticals, biotechnology, and diagnostics with an innovative solution for identifying and validating novel disease markers.<br />
Life Sciences Research | 28/08/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy